A Phase III study of Fludarabine and Busulfan versus Fludarabine, Busulfan and low dose total body irradiation in patients receiving an allogeneic hematopoietic stem cell transplant - Regional Cancer Care Associates LLC

Clinical Trials

A Phase III study of Fludarabine and Busulfan versus Fludarabine, Busulfan and low dose total body irradiation in patients receiving an allogeneic hematopoietic stem cell transplant

Type of Cancer

Warning: implode(): Invalid arguments passed in /home/region33/public_html/wp-content/themes/regionalcancercenter/single-clinical-trials.php on line 42
Locations
Sponsor
Hackensack UMC
Protocol Number
Hackensack UMC 00001278
Cancer Diagnosis
To Learn More Call
201-510-0910